
Longésanté
La Lutte Contre le Vieillissement : Mécanismes, Innovations et Implications
Découvrez comment la médecine moderne pourrait transformer notre compréhension du vieillissement et de la longévité.

Loading…
Longésanté vous fait découvrir les recherches et innovations dans le domaine de la longévité en bonne santé. Chaque épisode explore une découverte scientifique récente, expliquée simplement.
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
25%
Guest openness
Selective
Sign up to generate a grounded pitch for Longésanté.
Signup to Generate a PitchLongésanté is a health podcast hosted by Unknown Host, with 10 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
Unknown Host hosts Longésanté, a health show with 10 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

Longésanté
Découvrez comment la médecine moderne pourrait transformer notre compréhension du vieillissement et de la longévité.

Longésanté
Découvrez comment le programme Prolon® de L-Nutra révolutionne la santé métabolique grâce à une nutrition clinique innovante.

Longésanté
Découvrez le probiotic CLB101, une avancée majeure en santé intestinale, lancé par Designs for Health et ClostraBio. En savoir plus !

Longésanté
Découvrez comment Telomir-1 pourrait révolutionner le traitement des troubles neurodégénératifs et améliorer la longévité cellulaire.

Longésanté
Découvrez comment NRG Therapeutics prépare le terrain pour NRG5051, un nouvel inhibiteur prometteur dans la lutte contre les maladies neurodégénératives.
Sponsor detection runs nightly. Check back soon.
Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.